China Universal Asset Management Company’s Fulcrum Therapeutics FULC Stock Holding History

China Universal Asset Management Company’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.8K	Sell	10,605 -1,214	-10%	-$7.38K	﹤0.01%	472
2026 Q1	$90.7K	Buy	11,819 +3,000	+34%	+$27.8K	0.01%	412
2025 Q4	$99.7K	Buy	+8,819	New	+$89.7K	0.01%	411
2024 Q4	–	Sell	-12,002	Closed	-$42.8K	–	509
2024 Q3	$42.8K	Buy	12,002 +4,701	+64%	+$34.9K	﹤0.01%	393
2024 Q2	$45.3K	Sell	7,301 -4,615	-39%	-$35K	0.01%	364
2024 Q1	$112K	Buy	11,916 +4,766	+67%	+$42.5K	0.01%	364
2023 Q4	$48.3K	Buy	7,150 +5,556	+349%	+$24.7K	0.01%	375
2023 Q3	$7.08K	Buy	1,594 +784	+97%	+$3.43K	﹤0.01%	368
2023 Q2	$2.67K	Sell	810 -26	-3%	-$76	﹤0.01%	413
2023 Q1	$2.38K	Buy	836 +307	+58%	+$2.75K	﹤0.01%	425
2022 Q4	$3.85K	Buy	529 +42	+9%	+$274	﹤0.01%	328
2022 Q3	$4K	Buy	+487	New	+$3.49K	﹤0.01%	297

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

China Universal Asset Management Company's FULC Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Fulcrum Therapeutics (FULC) stake by 10% in Q2 2026, selling an estimated $7.38K and leaving 10,605 shares worth $38.8K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

China Universal Asset Management Company first reported a position in FULC in Q3 2022 and has held it in 12 quarters since. The position peaked at $112K in Q1 2024. 71 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

China Universal Asset Management Company held 10,605 shares of Fulcrum Therapeutics worth $38.8K as of Q2 2026.
China Universal Asset Management Company sold 1,214 Fulcrum Therapeutics shares in Q2 2026, an estimated $7.38K.
Fulcrum Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #472 holding.
China Universal Asset Management Company first reported a position in Fulcrum Therapeutics in Q3 2022 and has held it in 12 quarters since.
China Universal Asset Management Company's Fulcrum Therapeutics position peaked at $112K in Q1 2024.
71 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.